Home Dialysis News

A Canadian study that compared patients who started on peritoneal dialysis vs. in-center hemodialysis found PD offered lower costs and better quality of life.

Patients who initiated kidney replacement therapy on peritoneal dialysis were treated more cost-effectively than patients who were started on in-center hemodialysis, according to results of a cost-analysis conducted in Canada.

There has been a great deal of focus recently in getting more patients interested in home dialysis.

Health care providers should try to decrease frequency of infections, which are the leading cause of technique failure, and increase a patient’s odds for successful treatment or return to peritoneal dialysis, according to a speaker.

Home hemodialysis programs require investment in patients, staff, infrastructure and executive leadership to grow successfully and comply with federal models, according to a speaker at ASN Kidney Week.

Beginning or growing a peritoneal dialysis program requires knowledgeable staff who can reach as many potential patient candidates as possible, according to a speaker at ASN Kidney Week.

When a multidisciplinary team provides appropriate education and ongoing support, patients may be more likely to initiate kidney replacement therapy with peritoneal dialysis, according to a speaker at the virtual ASN Kidney Week.

Based on more than 20 years of experience, a speaker at ASN Kidney Week discussed the role of the home dialysis training nurse, emphasizing the importance of tailoring training to best support individual patients and their families.

A speaker at the virtual ASN Kidney Week discussed what she termed the “top five mistakes” clinicians make when prescribing peritoneal dialysis, highlighting that many current approaches do not fully consider patient preferences.

The FDA has approved Fresenius Medical Care North America’s Delflex peritoneal dialysis solutions in Biofine, a new bag material that is more efficient and environmentally friendly, according to a press release.